Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
11 (
03
); 229-234
doi:
10.1055/s-0042-1743162

Maximal Thymectomy via Mini Sternotomy with Pleural Preservation

Department of Surgical Oncology, Bombay Hospital and Medical Research Centre, Marine Lines, Mumbai, Maharashtra, India

*Corresponding author: Gaurav Patel, MBBS, MS, Mumbai-400020, Maharashtra, India. gauravdp49@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Gaurav Patel
FI2180602-4 Gaurav Patel

Background There are different surgical techniques used for maximal thymectomy. Each technique has its own advantages and disadvantages. We propose a mini sternotomy with pleural preservation approach for complete maximal thymectomy.

Methods Over time range of 5 years, 32 patients with diagnosis of thymoma with or without myasthenia gravis (MG) underwent maximal thymectomy by mini sternotomy in our institute. Patient records were examined for the following parameters: age, sex, preoperative medication, symptoms of MG as per Myasthenia Gravis Foundation of America grading system, operating time, duration of postoperative ventilation, length of stay in the intensive care unit, overall length of hospitalization, and postoperative complications.

Results The mean age of patients in our study was 43.66. Sex ratio in this study was almost equal. Sixty-nine percent of patients were stage I thymoma according to Masaoka staging. Size of the tumor ranged from 3 to 8 cm with mean size being 4.54 cm. Complete resection with negative tumor margins was possible in all the cases. Four patients had intraoperative pleural injury out of which two patients required intercostal tube insertion. We did not have any serious postoperative complications with no perioperative mortality.

Conclusions Mini sternotomy allows maximal removal of thymus through a less invasive approach and is associated with a significantly smoother postoperative course, less overall complications, and good clinical outcome. It is a simple technique that can be performed by any thoracic and surgical oncologists especially in Indian subcontinent where facilities of video-assisted thoracoscopic surgery and robotic video-assisted thoracoscopic surgery are not available in all areas and are expensive.

Keywords

PubMed

Introduction

Thymoma, the most common neoplasm of the thymus gland, originates from its epithelial tissue. Thymomas are also the most common neoplasm of the anterior mediastinum in adults that account for ∼50%.1 The incidence of thymoma is 0.15 per 1,00,000 person years.2 They have frequent association with various paraneoplastic syndromes with myasthenia gravis (MG) being most common.1

Maximal thymectomy is the main treatment for thymoma. The traditional approach is through a median complete sternotomy, but, recently minimally invasive approaches in the form of video-assisted thoracoscopic surgery (VATS) and robotic video-assisted thoracoscopic surgery (R-VATS) are increasingly being performed.345 Each of these approaches have their own advantages and disadvantages. Complete median sternotomy though gives the best exposure but it is too morbid procedure considering the need of elective postoperative ventilation in few cases, higher doses of postoperative analgesia including opioids and it requires intercostal drain (ICD) tube insertion, if pleura is opened, which all adds to restriction of breathing efforts and leads to atelectasis. Complete transcervical approach leads to incomplete excision of gland and more complications. VATS, though is less painful procedure, requires bilateral approach for the completion of thymectomy, thus needing bilateral ICD tube insertion and it is difficult to excise the suprainnominate vein extension of the thymic gland, thus leaving some thymic tissue at the root of neck. R-VATS provides good exposure, but the cost and availability are a major drawback in India.

We propose a mini sternotomy with pleural preservation approach for complete maximal thymectomy. It has the advantage of adequate exposure of the entire thymus gland and the perithymic tissue with minimum morbidity by obviating the need of ICD tube insertion, no elective postoperative ventilation, lesser pain, and lesser incidence of respiratory complication. It does not have a steep learning curve as VATS and R-VATS without any need of special armamentarium, which can be done by any thoracic or surgical oncologist in remote places of the country.

Patients and Methods

Over time range of 5 years, 32 patients with diagnosis of thymoma with or without MG underwent maximal thymectomy by mini sternotomy in our institute. Inclusion criteria were the presence of thymoma stage I and II as per Masaoka staging, regardless of age or sex. Exclusion criteria were the presence of chest deformities, infiltrating thymoma, associated pulmonary and cardiac pathology, and the presence of a myasthenic crisis in a diagnosed case of MG.

Patient records were examined for the following parameters: age at surgery, patient sex, preoperative medication, medically optimized preoperative level of symptoms for MG patients according to Myasthenia Gravis Foundation of America (MGFA) grading system, operating time, duration of postoperative ventilation, length of stay in the intensive care unit, overall length of hospitalization, and postoperative complications.

Preoperative medications were administered till the morning of surgery, as prescribed by the neurologist.

During anesthesia, the administration of muscle blocking agents was avoided. Intravenous opioids were used cautiously. The operation was performed under general anesthesia using a single lumen tube.

A vertical midline skin incision is made starting just below the suprasternal notch up to the level of the third cartilage. The incision is carried down to the sternal periosteum. “L”-shaped mini sternotomy is made starting from the suprasternal notch up to upper border of third cartilage. With the sternum retracted, adequate visualization of the thymus and its cervical extensions is obtained. Thymus gland is first dissected off the innominate vein. Superior horns are resected from lower pole of thyroid bilaterally. Pleura is dissected off from both the hilum's and safeguarded. This is achieved by careful hand-controlled ventilation by anesthetist. Thymic tissue is then dissected off from the innominate vein till superior vena cava on right side and left pulmonary hilum on left side. Both phrenic nerves are identified and preserved. The inferior horns are dissected off the pericardium with its associated pericardial fat pad (Figs. 123).

(A) Exposure of sternum up to third rib space, safe guarding ipsilateral internal mammary artery before cutting bone; (B) performing partial sternotomy using motorized saw; (C) excision of thymus gland and perithymic tissue along with thyrothymic ligaments.
Fig. 1: (A) Exposure of sternum up to third rib space, safe guarding ipsilateral internal mammary artery before cutting bone; (B) performing partial sternotomy using motorized saw; (C) excision of thymus gland and perithymic tissue along with thyrothymic ligaments.
(A) Postoperative bed after complete maximal thymectomy showing the bare innominate vein; (B) closure of the sternum using stainless steel wires; (C) closure of the skin with clips after insertion of negative pressure 12 Fr drain.
Fig. 2: (A) Postoperative bed after complete maximal thymectomy showing the bare innominate vein; (B) closure of the sternum using stainless steel wires; (C) closure of the skin with clips after insertion of negative pressure 12 Fr drain.
(A) Incision planning for partial sternotomy approach; (B) postoperative scar after 1 month follow-up.
Fig. 3: (A) Incision planning for partial sternotomy approach; (B) postoperative scar after 1 month follow-up.

Complete removal of the thymus and perithymic tissue is done that includes tissue between the superior vena cava on right side, pulmonary conus and aortic arch on left side, lower pole of thyroid superiorly including superior horns of thymus, pericardial sac, and mediastinal pleura inferiorly that constitute maximal thymectomy.

Meticulous exploration in terms of completion of procedure and hemostasis is performed. Before closure, a 12 Fr negative pressure drain is placed in the anterior mediastinum. ICD is inserted only if there is major pleural injury. The sternum is then sutured with stainless steel threads. Further closure is done in layers to conclude the procedure. A full sternotomy to complete the operation was not needed in our series.

Successful postoperative management of these patients requires close cooperation among the neurologist, operating surgeon, nurses, and physiotherapists. Patients were extubated in the operating room if possible. The prerequisite was enough muscle power to breathe spontaneously with satisfactory gas exchange. After surgery, all patients were taken to the intensive care unit. Patients can have soft or full diet on the evening of surgery. In case of MG patients, preoperative medications are resumed as soon as the patient is started on oral feeds. Negative pressure drain is removed on third postoperative day depending on its measurement. A neurology team is responsible for the late follow-up; therefore, medications are adjusted according to the symptoms on outpatient basis.

Results

A total of 32 patients were enrolled in this study. Of these 32 patients, 30 patients were known case of MG and had anterior mediastinal mass in computer tomography (CT) scan. Rest was incidental anterior mediastinal mass that on CT-guided biopsy suggested of thymoma.

The mean age of patients was 43.66. Sex ratio was almost equal. There was no perioperative mortality.

Grades of myasthenia gravis as per MGFA:

Grade of MG

Number

Percentage

I

8

26.6

IIA

14

46.6

IIB

5

16.6

IIIA

3

10

≥IIIB

0

0

Total

30

100

In the patients with MG, majority (46.6%) had Grade IIA symptoms as per MGFA, followed by Grade I and Grade IIB symptoms. None of the patients had Grade IIIB and severe symptoms.

Sixty nine percent of patients were stage I thymoma according to Masaoka staging. Size of the tumor ranged from 3 to 8 cm with mean size being 4.54 cm.

Complete resection with negative tumor margins was possible in all the cases. Four patients had intraoperative pleural injury out of which two patients required pleura and lung wedge resection and hence ICD tube placement. All patients were extubated in operating room and none required reintubation in postoperative period. The mean operating time was 139.7 minutes and mean intensive care and hospital stay were 4 and 8.2 days, respectively. Intraoperative blood loss was minimal and none of our patient required any blood transfusion.

We did not have any serious complications related to mini sternotomy; pain control was adequate with transdermal fentanyl patch (25 µg), no reoperation in our series, no postoperative bleeding, mediastinitis, pneumonitis or pneumonia, no serious collections in the subcutaneous space, good cosmetic results, and no diaphragmatic palsy was detected by postoperative roentgenogram. There was no residual pneumothorax or hemothorax.

Discussion

Thymoma, although is a rare disease, represents the most common primary mediastinal neoplasm in adults. Thymectomy is an important component in the treatment of thymoma and anterior mediastinal tumors, while stage and radical resection are considered as very important predictors of survival. Presence of MG is not an independent prognostic factor but may play a role in early detection of thymic tumors.6 About one third are associated with MG and their resection significantly improves the symptoms of MG.

Since the first thymectomy reported in 1939,7 there has been growing interest in developing minimally invasive approaches to reduce the morbidity of conventional sternotomy. The beneficial effect of thymectomy is thought to be maximized by the removal of all thymic tissue, including ectopic thymic tissue.89 Hence, concern about obtaining less morbidity results should not reduce the ability to achieve radical resection of thymic tissue, which remains the primary objective of surgery.

Thymectomy may be performed by median sternotomy1011 (with or without a transcervical extension), partial sternotomy,12 a transcervical incision,13 transcervical incision combined to partial sternotomy,14 and more recently, VATS and R-VATS.1516171819

As with any of these techniques, the surgeon must excise complete thymic tissue. With the use of any above-described approach, the incision should be enlarged or the technique should be changed whenever there is the slightest chance of unsatisfactory resection. Removal should be deemed unsatisfactory whenever the thymus gland is torn by surgical traction or is withdrawn in pieces. In the largest retrospective analysis of thymectomy, 92% of patients achieved an R0 resection. Survival at 5 years for stage I, II, III, and IVa was 100, 98, 89, and 71%, respectively, and at 10 years was 100, 98, 78, and 47%, respectively. This study illustrated that complete microscopic resection is achievable in a large proportion of cases and that survival after an R0 resection was significantly higher, establishing that complete surgical resection is the best therapeutic modality for thymoma.20 Similar results have been reported in other series.21222324 The transcervical approach to perform thymectomy is a less invasive approach, with good aesthetic results and fast recovery. However, it definitely provides poorer visualization of the thymus and surrounding structures, especially in cases of thymoma, compared with total or partial longitudinal sternotomy.25 Although in literature there are studies performing thoracoscopic unilateral hemi/partial thymectomy and even thymectomy with positive margins that is against the principle of oncology, we suggest future trials to know the different extents of resection for thymoma with respect to efficacy and safety.262728 In our series with mini sternotomy, R0 resection was achieved in all the patients with no recurrence in 5 years follow-up and reduction in dosage and drugs for MG treatment were also seen over the months postsurgery.

From technical point of view, unilateral VATS may give multiple challenges. Resection of tissue in the right cardiophrenic angle and within the confluence of the superior vena cava and innominate vein can be challenging using a left-sided approach, while a right-sided approach could limit resection of tissue in the left-sided cardiophrenic angle fat and/or at the level of the aortopulmonary window. Hence, maximal thymectomy via VATS or R-VATS will require bilateral approach with bilateral ICD tubes placement, thus increasing the morbidity. In our series, 93.75% of patients did not require any ICD placement.

The mean operative time taken together in few comparative studies between VATS and open thymectomy is 203.8 and 173.2 minutes, respectively.2829303132 Similarly in comparative studies between R-VATS and open thymectomy, the mean operative time taken together was 151 and 97.3 minutes, respectively.33343536 This is possibly due to the more complex operative setup required for minimal invasive surgery, but has also been demonstrated to be as a result of the inevitable learning curve that comes with the use of these new techniques. Mean operative time in our series was 139.7 minutes.

As far as mean hospital stay and intensive care stay are concerned, VATS and R-VATS showed fewer days than transsternal approach. Few of comparative studies between VATS and open thymectomy show mean hospital stay of 8.4 and 12.2 days, respectively,28293031 whereas studies between R-VATS and open thymectomy show 3.9 and 7.3 days, respectively.33343536 Mean intensive care stay for open, VATS, and R-VATS thymectomy in various studies was 1.5, 1.4, and around 1 day, respectively.282930313738 In our series of mini sternotomy, mean intensive care stay and hospital stay were 4 and 8.2 days, respectively. Intensive care stay was more in our series to keep a check on myasthenic crisis as most of our patients were of MG (93.75%) and it was also as per the instructions from our neurology team.

Although inconsistently reported across the studies, there are certain potential complications associated with VATS and R-VATS including phrenic nerve injury and increase risk of pleural dissemination of tumor. These complications may be increased in the initial stages of the learning curve associated with VATS thymectomy and excessive manipulation of the thymoma in the restricted working space of the anterior mediastinum, making the tumor capsule more prone to tearing, as well as incision of the mediastinal pleura, which may facilitate seeding of tumor cells.293940 None of our patients had phrenic nerve injury or pleural dissemination of tumor, which is similar to other transsternal thymectomy studies.2941

In our series, none of the patient had any complications in terms of excessive pain, postoperative bleeding, mediastinitis, pneumonitis, pneumonia, pneumothorax, hemothorax, no serious collections in the subcutaneous space, no reoperation or any diaphragmatic palsy detected in postoperative roentgenogram. In general, extubation is delayed for few hours with fear of patient not able to breathe because of pain or muscle weakness due to MG. But in our experience, mini sternotomy with pleural preservation, patients had no ICD tube insertion; hence, pain was controlled well that led to minimal respiratory restriction. All the patients in our series were extubated in the operating room and none required reintubation in the postoperative period.

Most of the studies have taken complete median sternotomy for comparison and hence it shows more complications in postoperative period than VATS and R-VATS. Furthermore, most of the authors use the VATS approach when the tumor diameter is less than 5 cm, not involving the innominate vein, with little or no evidence of invasion or compression of major mediastinal structures.42 There is a great advantage to mini sternotomy for maximal thymectomy, as the possibilities of pain, wound infection, mediastinitis, pulmonary complications, and sternal destabilization/dehiscence are much lower than complete sternotomy and avoidance of ICD tube placement and its associated morbidities in compared with VATS and R-VATS.

Thus, trans-sternal approach is currently considered as the gold standard approach for thymic resection. However, interest has grown in minimally invasive surgical approaches, most notably VATS and R-VATS thymectomy. There are various comparison studies among these various approaches, but they have their own limitations as they are nonrandomized, observational in nature, with small sample sizes, and insufficient and/or inconsistent reporting of outcomes including long-term survival, recurrence rates, and postoperative complications. As mentioned before, most of the trials included complete median sternotomy rather than mini sternotomy that is less invasive and has far lesser morbidities than the complete sternotomy.

Conclusion and Recommendation

Although the number of patients is small, our data indicate that thymectomy through mini sternotomy allows maximal removal of thymus through a less invasive approach and is associated with a significantly smoother postoperative course and less overall complications. The clinical outcome is very encouraging. Mini sternotomy can be considered as minimal access, as it allows maximal thymectomy and improves the operative outcome in terms of pain control, hospital stay, and good cosmetic results. Additionally, it is a simple technique to perform, easy to teach and learn, and uses conventional surgical instruments. This approach deserves the attention of all thoracic and surgical oncologists especially in Indian subcontinent because of the ease of the procedure and where facilities of VATS and R-VATS are not available in all areas and are expensive.

References

  1. , , . Thymic tumors. Ann Thorac Surg. 2004;77(05):1860-1869.
    [Google Scholar]
  2. , , , , . Natural history and treatment of malignant thymoma. Oncology (Williston Park). 1998;12(07):1001-1005.
    [Google Scholar]
  3. , , , et al . Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes. Eur J Cardiothorac Surg. 2015;48(01):40-45.
    [Google Scholar]
  4. , . Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2014;62(08):468-474.
    [Google Scholar]
  5. , , , , , , . VATS thymectomy for nonthymomatous myasthenia gravis: standardized outcome assessment using the myasthenia gravis foundation of America clinical classification. Innovations (Phila). 2011;6(02):104-109.
    [Google Scholar]
  6. , , , , . A review of prognostic factors in thymic malignancies. J Thorac Oncol. 2011;6:S1698-S1704.
    [Google Scholar]
  7. , , , , . Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed. Ann Surg. 1939;110(04):544-561.
    [Google Scholar]
  8. , , , et al . Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg. 1996;62(03):853-859.
    [Google Scholar]
  9. , , , et al . “Maximal” thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg. 1988;95(05):747-757.
    [Google Scholar]
  10. , , , et al . Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases. Ann Thorac Surg. 1999;67(06):1568-1571.
    [Google Scholar]
  11. , , , et al . Transsternal radical thymectomy for myasthenia gravis: a 15-year review. Ann Thorac Surg. 1989;47(06):838-840.
    [Google Scholar]
  12. , , , . Reversed-T upper mini-sternotomy for extended thymectomy in myasthenic patients. Ann Thorac Surg. 2000;70(04):1423-1424.
    [Google Scholar]
  13. , , , . Studies in myasthenia gravis. Transcervical total thymectomy. JAMA. 1969;209(06):906-910.
    [Google Scholar]
  14. , . The combined cervical and partial sternotomy approach for thymectomy. Chest Surg Clin N Am. 1996;6(01):85-93.
    [Google Scholar]
  15. , , , , . Video-assisted thoracoscopic surgery or transsternal thymectomy in the treatment of myasthenia gravis? Interact Cardiovasc Thorac Surg. 2011;12(01):40-46.
    [Google Scholar]
  16. , , . Video-assisted thoracoscopic surgery versus sternotomy in thymectomy for thymoma and myasthenia gravis. Ann Cardiothorac Surg. 2016;5(01):33-37.
    [Google Scholar]
  17. , , , , , , . Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes. Ann Cardiothorac Surg. 2016;5(01):1-9.
    [Google Scholar]
  18. , , , et al . Minimally invasive thymectomy: the Mayo Clinic experience. Ann Cardiothorac Surg. 2015;4(06):519-526.
    [Google Scholar]
  19. , , , et al . Video-assisted thoracoscopic versus robotic-assisted thoracoscopic thymectomy: systematic review and meta-analysis. Innovations (Phila). 2017;12(04):259-264.
    [Google Scholar]
  20. , , . Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;76(03):878-884.
    [Google Scholar]
  21. , , , , , . Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest. 2005;127(03):755-761.
    [Google Scholar]
  22. , , , et al . Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg. 2004;26(02):412-418.
    [Google Scholar]
  23. , , , , , . Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys. 2004;60(04):1113-1119.
    [Google Scholar]
  24. , , , et al . Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003;126(04):1134-1140.
    [Google Scholar]
  25. , . Transcervical thymectomy. Semin Thorac Cardiovasc Surg. 1999;11(01):59-64.
    [Google Scholar]
  26. , , , et al . Limited thymectomy for stage I or II thymomas. Lung Cancer. 2010;68(03):460-465.
    [Google Scholar]
  27. , , , et al . Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol. 2013;8(07):952-958.
    [Google Scholar]
  28. , , , et al . Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma. Eur J Cardiothorac Surg. 2010;37(04):824-826.
    [Google Scholar]
  29. , , , et al . Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma. Eur J Cardiothorac Surg. 2014;45(06):e187-e193.
    [Google Scholar]
  30. , , , , , , . Surgical approaches for stage I and II thymoma-associated myasthenia gravis: feasibility of complete video-assisted thoracoscopic surgery (VATS) thymectomy in comparison with trans-sternal resection. J Biomed Res. 2013;27(01):62-70.
    [Google Scholar]
  31. , , , et al . The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas. Eur J Cardiothorac Surg. 2013;44(03):e214-e218.
    [Google Scholar]
  32. , , , et al . Thoracoscopic versus transsternal resection for early stage thymoma: long-term outcomes. Surg Today. 2014;44(12):2275-2280.
    [Google Scholar]
  33. , , , et al . A comparison of outcomes after robotic open extended thymectomy for myasthenia gravis. Eur J Cardiothorac Surg. 2007;31(03):501-504.
    [Google Scholar]
  34. , , , , , , . Robotic thymectomy: learning curve and associated perioperative outcomes. J Laparoendosc Adv Surg Tech A. 2017;27(07):685-690.
    [Google Scholar]
  35. , , , et al . Robotic-assisted thymectomy with Da Vinci II versus sternotomy in the surgical treatment of non-thymomatous myasthenia gravis: early results. Rev Neurol (Paris). 2013;169(01):30-36.
    [Google Scholar]
  36. , , , et al . Early clinical outcomes of robot-assisted surgery for anterior mediastinal mass: its superiority over a conventional sternotomy approach evaluated by propensity score matching. Eur J Cardiothorac Surg. 2014;45(03):e68-e73.
    [Google Scholar]
  37. , , , , , . Long-term follow-up after robotic thymectomy for nonthymomatous myasthenia gravis. Ann Thorac Surg. 2011;92(03):1018-1022.
    [Google Scholar]
  38. , , , , , . Comparison of perioperative outcomes of videothoracoscopy and robotic surgical techniques in thymoma. Asian J Surg. 2020;43(01):244-250.
    [Google Scholar]
  39. , , , , , . Does a relationship exist between the number of thoracoscopic thymectomies performed and the learning curve for thoracoscopic resection of thymoma in patients with myasthenia gravis? Interact Cardiovasc Thorac Surg. 2011;12(02):152-155.
    [Google Scholar]
  40. , , , et al . Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg. 2009;137(05):1185-1189.
    [Google Scholar]
  41. , , , , , , . Long-term outcome for early stage thymoma: comparison between thoracoscopic and open approaches. Thorac Cardiovasc Surg. 2015;63(03):201-205.
    [Google Scholar]
  42. , , , et al . Surgical approach in thymectomy: our experience and review of the literature. Int J Surg Case Rep. 2017;39:19-24.
    [Google Scholar]
Show Sections